{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:59:03Z","timestamp":1785448743070,"version":"3.56.0"},"reference-count":124,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psychiatry stands at a turning point, where molecular insights promise to revolutionize how we diagnose, monitor, and treat neuropsychiatric conditions, including Alzheimer\u2019s, Parkinson\u2019s, depression, dementia, and schizophrenia (SCZ), among others [...]<\/jats:p>","DOI":"10.3390\/ijms262010238","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:19Z","timestamp":1761058399000},"page":"10238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Special Issue \u201cTranslating Molecular Psychiatry: From Biomarkers to Personalized Therapies\u201d"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-4024","authenticated-orcid":false,"given":"Masaru","family":"Tanaka","sequence":"first","affiliation":[{"name":"Danube Neuroscience Research Laboratory, HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Tisza Lajos krt. 113, H-6725 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tins.2017.10.006","article-title":"The Emerging Neurobiology of Bipolar Disorder","volume":"41","author":"Harrison","year":"2018","journal-title":"Trends Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.21078","article-title":"Candidate biomarkers in psychiatric disorders: State of the field","volume":"22","author":"Moeller","year":"2023","journal-title":"World Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Waszkiewicz, N. (2020). Mentally Sick or Not-(Bio)Markers of Psychiatric Disorders Needed. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082375"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2015.02.029","article-title":"Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types","volume":"449","author":"Dacquino","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tanaka, M. (2025). Parkinson\u2019s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation. Cells, 14.","DOI":"10.20944\/preprints202506.2099.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10571-019-00684-6","article-title":"The Missing Link: How Exosomes and miRNAs can Help in Bridging Psychiatry and Molecular Biology in the Context of Depression, Bipolar Disorder and Schizophrenia","volume":"39","author":"Gruzdev","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"pyaf025","DOI":"10.1093\/ijnp\/pyaf025","article-title":"Moving toward precision and personalized treatment strategies in psychiatry","volume":"28","author":"Comai","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e073591","DOI":"10.1136\/bmj-2022-073591","article-title":"Diagnosis and management of bipolar disorders","volume":"381","author":"Goes","year":"2023","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/jamapsychiatry.2018.2467","article-title":"Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models","volume":"75","author":"Wolfers","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/pcn.13337","article-title":"Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings","volume":"76","author":"Cheon","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1021\/acschemneuro.2c00420","article-title":"Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process","volume":"13","author":"Mandal","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.17219\/acem\/197425","article-title":"Beyond the boundaries: Transitioning from categorical to dimensional paradigms in mental health diagnostics","volume":"33","author":"Tanaka","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Capatina, T.F., Oatu, A., Babasan, C., and Trifu, S. (2025). Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies\u2014A Narrative Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094285"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Guti\u00e9rrez, M.S., Navarrete, F., Sala, F., Gasparyan, A., Austrich-Olivares, A., and Manzanares, J. (2020). Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00432"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000443549","article-title":"Biomarkers in Psychiatry\u2014A Critique","volume":"23","author":"Venkatasubramanian","year":"2016","journal-title":"Ann. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"115064","DOI":"10.1016\/j.psychres.2023.115064","article-title":"Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention","volume":"321","author":"Do","year":"2023","journal-title":"Psychiatry Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/appi.ajp.2020.20030340","article-title":"Neuroimaging Biomarkers in Schizophrenia","volume":"178","author":"Kraguljac","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40291-020-00464-9","article-title":"Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders","volume":"24","author":"Roy","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tanaka, M., and V\u00e9csei, L. (2025). From Microbial Switches to Metabolic Sensors: Rewiring the Gut-Brain Kynurenine Circuit. Biomedicines, 13.","DOI":"10.20944\/preprints202506.0880.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41386-024-01907-1","article-title":"Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression","volume":"50","author":"Prompiengchai","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.4190","article-title":"The search for imaging biomarkers in psychiatric disorders","volume":"22","author":"Horga","year":"2016","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, \u00c1., Galla, Z., Spekker, E., Sz\u0171cs, M., Martos, D., Takeda, K., Ozaki, K., Inoue, H., Yamamoto, S., and Toldi, J. (2025). Oxidative and Excitatory Neurotoxic Stresses in CRISPR\/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder. Front. Biosci., 30.","DOI":"10.31083\/FBL25706"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14789450.2017.1375857","article-title":"Innovative biomarkers in psychiatric disorders: A major clinical challenge in psychiatry","volume":"14","author":"Lozupone","year":"2017","journal-title":"Expert. Rev. Proteomics"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kraus, B., Zinbarg, R., Braga, R.M., Nusslock, R., Mittal, V.A., and Gratton, C. (2023). Insights from personalized models of brain and behavior for identifying biomarkers in psychiatry. Neurosci. Biobehav. Rev., 152.","DOI":"10.1016\/j.neubiorev.2023.105259"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Berdeville, C., Silva-Amaral, D., Dalgalarrondo, P., Banzato, C.E.M., and Martins-de-Souza, D. (2025). A scoping review of protein biomarkers for schizophrenia: State of progress, underlying biology, and methodological considerations. Neurosci. Biobehav. Rev., 168.","DOI":"10.1016\/j.neubiorev.2024.105949"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"R\u00edos, U., P\u00e9rez, S., Mart\u00ednez, C., Moya, P.R., and Arancibia, M. (2025). Inflammation and Cognition in Bipolar Disorder: Diverging Paths of Interleukin-6 and Outcomes. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136372"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bottaccioli, A.G., Bologna, M., and Bottaccioli, F. (2025). Rethinking Depression-Beyond Neurotransmitters: An Integrated Psychoneuroendocrineimmunology Framework for Depression\u2019s Pathophysiology and Tailored Treatment. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062759"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Trovini, G., Lombardozzi, G., Kotzalidis, G.D., Lionetto, L., Russo, F., Sabatino, A., Serra, E., Castorina, S., Civita, G., and Frezza, S. (2025). Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031394"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, F., Zhang, J., Wang, X., Han, M., Fei, Y., and Wang, J. (2025). Blood-Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030873"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Checa-Robles, F.J., Salvetat, N., Cayzac, C., Menhem, M., Favier, M., Vetter, D., Ouna, I., Nani, J.V., Hayashi, M.A.F., and Brietzke, E. (2024). RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312981"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"\u0218erban, M., Toader, C., and Covache-Busuioc, R.A. (2025). Brain Tumors, AI and Psychiatry: Predicting Tumor-Associated Psychiatric Syndromes with Machine Learning and Biomarkers. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178114"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Barbalho, S.M., Laurindo, L.F., de Oliveira Zanuso, B., da Silva, R.M.S., Gallerani Caglioni, L., Nunes Junqueira de Moraes, V.B.F., Fornari Laurindo, L., Dogani Rodrigues, V., da Silva Camarinha Oliveira, J., and Beluce, M.E. (2025). AdipoRon\u2019s Impact on Alzheimer\u2019s Disease-A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020484"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ayash, T.A., Allard, M.J., Chevin, M., and S\u00e9bire, G. (2024). IL-1 Blockade Mitigates Autism and Cerebral Palsy Traits in Offspring In-Utero Exposed to Group B Streptococcus Chorioamnionitis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111393"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Battaglia, S., and Liloia, D. (2025). Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson\u2019s, Alzheimer\u2019s, and Motor Neuron Disorders. Biomedicines, 13.","DOI":"10.3390\/biomedicines13051045"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: Systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamapsychiatry.2017.3191","article-title":"Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study","volume":"74","author":"Hartwig","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2017.06.001","article-title":"The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression","volume":"233","author":"Kageyama","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2024.04.022","article-title":"AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort","volume":"356","author":"Salvetat","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"115422","DOI":"10.1016\/j.psychres.2023.115422","article-title":"Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood","volume":"328","author":"Hayashi","year":"2023","journal-title":"Psychiatry Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2017.10.001","article-title":"On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review","volume":"83","author":"Pinto","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737175.2019.1550361","article-title":"Biomarkers for bipolar disorder: Current status and challenges ahead","volume":"19","author":"Teixeira","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.euroneuro.2022.06.001","article-title":"Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery","volume":"61","author":"Fernandes","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"eaat8127","DOI":"10.1126\/science.aat8127","article-title":"Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder","volume":"362","author":"Gandal","year":"2018","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00109-021-02070-6","article-title":"Dysregulation of circRNA expression in the peripheral blood of individuals with schizophrenia and bipolar disorder","volume":"99","author":"Mahmoudi","year":"2021","journal-title":"J. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpsychires.2019.09.009","article-title":"Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder","volume":"119","author":"Tasic","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2024.05.050","article-title":"Integrative ceRNA network analysis identifies unique and shared molecular signatures in Bipolar Disorder and Schizophrenia","volume":"176","author":"Bharadwaj","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1381612825666191216153508","article-title":"Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers","volume":"26","author":"Yamada","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101556","DOI":"10.1016\/j.imu.2024.101556","article-title":"Bioinformatics and systems biology approaches to identify molecular targets and pathways shared between schizophrenia and bipolar disorder","volume":"49","author":"Khatun","year":"2024","journal-title":"Inform. Med. Unlocked"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"112497","DOI":"10.1016\/j.celrep.2023.112497","article-title":"Deep proteomics identifies shared molecular pathway alterations in synapses of patients with schizophrenia and bipolar disorder and mouse model","volume":"42","author":"Aryal","year":"2023","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41380-018-0332-x","article-title":"Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence","volume":"25","author":"Smeland","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12065-019-00346-y","article-title":"Predicting bipolar disorder and schizophrenia based on non-overlapping genetic phenotypes using deep neural network","volume":"14","author":"Karthik","year":"2021","journal-title":"Evol. Intell."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","article-title":"Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes","volume":"173","author":"Ruderfer","year":"2018","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"i362","DOI":"10.1093\/ijnp\/pyae059.643","article-title":"Identifying the Unique Genetic Architecture of Schizophrenia Distinguished from Bipolar Disorder Using Genomic Structural Equation Modeling","volume":"28","author":"Jang","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuron.2022.10.031","article-title":"The miR-124-AMPAR pathway connects polygenic risks with behavioral changes shared between schizophrenia and bipolar disorder","volume":"111","author":"Namkung","year":"2023","journal-title":"Neuron"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Martos, D., L\u0151rinczi, B., Szatm\u00e1ri, I., V\u00e9csei, L., and Tanaka, M. (2025). Decoupling Behavioral Domains via Kynurenic Acid Analog Optimization: Implications for Schizophrenia and Parkinson\u2019s Disease Therapeutics. Cells, 14.","DOI":"10.20944\/preprints202504.1511.v1"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Szatm\u00e1ri, I., and V\u00e9csei, L. (2025). Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design. Pharmaceuticals, 18.","DOI":"10.20944\/preprints202503.2399.v2"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"111308","DOI":"10.1016\/j.brainresbull.2025.111308","article-title":"AdipoRon attenuates depression-like behavior in T2DM mice via inhibiting inflammation and regulating autophagy","volume":"224","author":"Zhao","year":"2025","journal-title":"Brain Res. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Brien, M.E., Gaudreault, V., Hughes, K., Hayes, D.J.L., Heazell, A.E.P., and Girard, S. (2021). A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010225"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 blockade in cardiovascular diseases: A clinical update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41386-024-01942-y","article-title":"Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging","volume":"50","author":"Gergues","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.stemcr.2021.12.015","article-title":"Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders","volume":"17","author":"Whiteley","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","article-title":"Neuroplasticity in cognitive and psychological mechanisms of depression: An integrative model","volume":"25","author":"Price","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","article-title":"Depression in cancer: The many biobehavioral pathways driving tumor progression","volume":"52","author":"Bortolato","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Tanaka, M. (2025). From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care. Biomedicines, 13.","DOI":"10.20944\/preprints202412.0679.v2"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13073-020-00734-5","article-title":"Translating insights from neuropsychiatric genetics and genomics for precision psychiatry","volume":"12","author":"Rees","year":"2020","journal-title":"Genome Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2021.10.863","article-title":"Stratified psychiatry: Tomorrow\u2019s precision psychiatry?","volume":"55","author":"Arns","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2024.08.515","article-title":"Towards a consensus roadmap for a new diagnostic framework for mental disorders","volume":"90","author":"Kas","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Dhieb, D., and Bastaki, K. (2025). Pharmaco-Multiomics: A New Frontier in Precision Psychiatry. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031082"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107008","DOI":"10.1016\/j.psyneuen.2024.107008","article-title":"A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression","volume":"164","author":"Foley","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_74","first-page":"32","article-title":"Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review","volume":"21","author":"Mario","year":"2024","journal-title":"Clin. Neuropsychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ruiz-Sastre, P., G\u00f3mez-S\u00e1nchez-Lafuente, C., Mart\u00edn-Mart\u00edn, J., Herrera-Imbroda, J., Mayoral-Cleries, F., Santos-Amaya, I., Rodr\u00edguez de Fonseca, F., Guzm\u00e1n-Parra, J., Rivera, P., and Su\u00e1rez, J. (2024). Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review. Prog. Neuropsychopharmacol. Biol. Psychiatry, 134.","DOI":"10.1016\/j.pnpbp.2024.111056"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2015.08.058","article-title":"Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications","volume":"188","author":"Rosenblat","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2020.03.073","article-title":"Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study","volume":"271","author":"Bavaresco","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tanaka, M., He, Z., Han, S., and Battaglia, S. (2025). Editorial: Noninvasive brain stimulation: A promising approach to study and improve emotion regulation. Front. Behav. Neurosci., 19.","DOI":"10.3389\/fnbeh.2025.1633936"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Figueiredo Godoy, A.C., Frota, F.F., Ara\u00fajo, L.P., Valenti, V.E., Pereira, E., Detregiachi, C.R.P., Galhardi, C.M., Caracio, F.C., Haber, R.S.A., and Fornari Laurindo, L. (2025). Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora. Biomedicines, 13.","DOI":"10.20944\/preprints202504.0573.v2"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Barbalho, S.M., Leme Boaro, B., da Silva Camarinha Oliveira, J., Pato\u010dka, J., Barbalho Lamas, C., Tanaka, M., and Laurindo, L.F. (2025). Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature. Pharmaceuticals, 18.","DOI":"10.20944\/preprints202412.1696.v2"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/ijmm.2025.5594","article-title":"Blood-brain barrier dysfunction in schizophrenia: Mechanisms and implications (Review)","volume":"56","author":"Lv","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Najjar, S., Pahlajani, S., De Sanctis, V., Stern, J.N.H., Najjar, A., and Chong, D. (2017). Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence. Front. Psychiatry, 8.","DOI":"10.3389\/fpsyt.2017.00083"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000511552","article-title":"The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia","volume":"6","author":"Pong","year":"2020","journal-title":"Complex Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Arango, C., Fagiolini, A., Gorwood, P., Kane, J.M., Diaz-Mendoza, S., Sahota, N., and Correll, C.U. (2023). Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery. BMC Psychiatry, 23.","DOI":"10.1186\/s12888-023-04928-0"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Verebi, C., Nectoux, J., Gorwood, P., Le Strat, Y., Duriez, P., Ramoz, N., and Bienvenu, T. (2023). A systematic literature review and meta-analysis of circulating nucleic acids as biomarkers in psychiatry. Prog. Neuropsychopharmacol. Biol. Psychiatry, 125.","DOI":"10.1016\/j.pnpbp.2023.110770"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41398-022-01938-6","article-title":"A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers","volume":"12","author":"Salvetat","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_87","first-page":"S573","article-title":"The RNA editing patterns are different in blood of euthymic and depressed bipolar patients","volume":"66","author":"Hayashi","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2023.01.001","article-title":"Multi-omics data integration methods and their applications in psychiatric disorders","volume":"69","author":"Sathyanarayanan","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s12551-021-00849-y","article-title":"Human disease biomarker panels through systems biology","volume":"13","author":"Smith","year":"2021","journal-title":"Biophys. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mokhtari, A., Porte, B., Belzeaux, R., Etain, B., Ibrahim, E.C., Marie-Claire, C., Lutz, P.E., and Delahaye-Duriez, A. (2022). The molecular pathophysiology of mood disorders: From the analysis of single molecular layers to multi-omic integration. Prog. Neuropsychopharmacol. Biol. Psychiatry, 116.","DOI":"10.1016\/j.pnpbp.2022.110520"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"113249","DOI":"10.1016\/j.expneurol.2020.113249","article-title":"AdipoRon improves cognitive dysfunction of Alzheimer\u2019s disease and rescues impaired neural stem cell proliferation through AdipoR1\/AMPK pathway","volume":"327","author":"Liu","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"114355","DOI":"10.1016\/j.expneurol.2023.114355","article-title":"AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer\u2019s disease","volume":"363","author":"Wang","year":"2023","journal-title":"Exp. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors","volume":"56","author":"Youngstein","year":"2017","journal-title":"Rheumatology"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Carnovale, C., Tombetti, E., Battini, V., Mazhar, F., Radice, S., Nivuori, M., Negro, E., Tamanini, S., and Brucato, A. (2020). Inflammasome Targeted Therapy in Pregnancy: New Insights from an Analysis of Real-World Data from the FAERS Database and a Systematic Review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.612259"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100602","DOI":"10.1016\/j.patter.2022.100602","article-title":"Modern views of machine learning for precision psychiatry","volume":"3","author":"Chen","year":"2022","journal-title":"Patterns"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lin, E., Lin, C.H., and Lane, H.Y. (2020). Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030969"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115955","DOI":"10.1016\/j.psychres.2024.115955","article-title":"Generative AI for precision neuroimaging biomarker development in psychiatry","volume":"339","author":"Wright","year":"2024","journal-title":"Psychiatry Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Tanaka, M., and Battaglia, S. (2025). Dualistic Dynamics in Neuropsychiatry: From Monoaminergic Modulators to Multiscale Biomarker Maps. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061456"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision Medicine, AI, and the Future of Personalized Health Care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Tossici, G., Zurloni, V., and Nitri, A. (2024). Stress and sport performance: A PNEI multidisciplinary approach. Front. Psychol., 15.","DOI":"10.3389\/fpsyg.2024.1358771"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1111\/jan.16087","article-title":"The relevance of the contribution of psychoneuroendocrinoimmunology and psychology of reasoning and decision making to nursing science: A discursive paper","volume":"80","author":"Milani","year":"2024","journal-title":"J. Adv. Nurs."},{"key":"ref_102","first-page":"e13729","article-title":"Functional medicine with dermatology insite: A systematic approach for diagnosis and treatment of chronic diseases","volume":"33","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13033-020-00410-6","article-title":"An integrative collaborative care model for people with mental illness and physical comorbidities","volume":"14","author":"Ee","year":"2020","journal-title":"Int. J. Ment. Health Syst."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Warren, A. (2023). An integrative approach to dementia care. Front. Aging, 4.","DOI":"10.3389\/fragi.2023.1143408"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/EDBK_320813","article-title":"Assessment and Management of Cognitive Symptoms in Patients With Brain Tumors","volume":"41","author":"Parsons","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-017-2670-y","article-title":"Initial psycho-oncological counselling in neuro-oncology: Analysis of topics and needs of brain tumour patients","volume":"136","author":"Schipmann","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-022-03993-x","article-title":"The burden of a brain tumor: Guiding patient centric care in neuro-oncology","volume":"157","author":"Loughan","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"AB068","DOI":"10.21037\/cco-24-ab068","article-title":"AB068. Psychiatric disorder in central nervous system tumor patients and its related factors","volume":"13","author":"Agiananda","year":"2024","journal-title":"Chin. Clin. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-017-2503-z","article-title":"Tumor-related neurocognitive dysfunction in patients with diffuse glioma: A systematic review of neurocognitive functioning prior to anti-tumor treatment","volume":"134","author":"Baumfalk","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"viii268","DOI":"10.1093\/neuonc\/noae165.1063","article-title":"QOL-28. Cancer-Related Distress in Neuro-Oncology: Patients Inform Program Development for Enhancing Quality of Life","volume":"26","author":"Fox","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ctrv.2018.02.007","article-title":"Cognitive disability in adult patients with brain tumors","volume":"65","author":"Ali","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","article-title":"Maternal immune activation and neuroinflammation in human neurodevelopmental disorders","volume":"17","author":"Han","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biopsych.2018.08.008","article-title":"Maternal Inflammation and Neurodevelopmental Programming: A Review of Preclinical Outcomes and Implications for Translational Psychiatry","volume":"85","author":"Gumusoglu","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41590-024-01797-x","article-title":"Prenatal and postnatal neuroimmune interactions in neurodevelopmental disorders","volume":"25","author":"Kim","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.biopsych.2017.09.030","article-title":"Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring","volume":"83","author":"Corradini","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-023-02911-w","article-title":"A systematic review of immune-based interventions for perinatal neuroprotection: Closing the gap between animal studies and human trials","volume":"20","author":"Kelly","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-024-03276-4","article-title":"Cytomegalovirus infection of the fetal brain: Intake of aspirin during pregnancy blunts neurodevelopmental pathogenesis in the offspring","volume":"21","author":"Tarhini","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Bauman, M.D., and Van de Water, J. (2020). Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model. Neurobiol. Dis., 141.","DOI":"10.1016\/j.nbd.2020.104864"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.biopsych.2016.10.020","article-title":"Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates","volume":"81","author":"Careaga","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: A systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"13657","DOI":"10.1039\/D2SC03932J","article-title":"Multipronged diagnostic and therapeutic strategies for Alzheimer\u2019s disease","volume":"13","author":"Ramesh","year":"2022","journal-title":"Chem. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","volume":"80","author":"Ashton","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Current state and future use in a transformed global healthcare landscape","volume":"111","author":"Hampel","year":"2023","journal-title":"Neuron"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s43587-022-00269-x","article-title":"Designing the next-generation clinical care pathway for Alzheimer\u2019s disease","volume":"2","author":"Hampel","year":"2022","journal-title":"Nat. Aging"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/10238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:35:42Z","timestamp":1761194142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/10238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":124,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms262010238"],"URL":"https:\/\/doi.org\/10.3390\/ijms262010238","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}